New Targeting in The Reversal of Resistant Glioblastomas

Ali Syed Arbab

doi:10.1016/C2019-0-04929-1

New Targeting in The Reversal of Resistant Glioblastomas

Research output: Book/Report › Book

Abstract

New Targeting in The Reversal of Resistant Glioblastomas discusses alternative treatment strategies that not only target tumor cells but also target the tumor microenvironment, metabolic pathways and interaction of cytokines in tumor cells. The current treatment for primary and recurrent glioblastomas is failing because clinicians are not considering the effect of bone marrow derived cells to the development of resistance to clinically practiced therapies. This book helps readers rethink treatment strategies to successfully fight glioblastomas. It is a valuable resource for cancer researchers, clinicians, graduate students and other members of the biomedical field.

Original language	English (US)
Publisher	Elsevier
Number of pages	180
ISBN (Electronic)	9780128225271
ISBN (Print)	9780128232767
DOIs	https://doi.org/10.1016/C2019-0-04929-1
State	Published - Jan 1 2021
Externally published	Yes

ASJC Scopus subject areas

General Agricultural and Biological Sciences
General Biochemistry, Genetics and Molecular Biology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/C2019-0-04929-1

Cite this

@book{3f4efeab584d40698cf52ecb3893cea9,

title = "New Targeting in The Reversal of Resistant Glioblastomas",

abstract = "New Targeting in The Reversal of Resistant Glioblastomas discusses alternative treatment strategies that not only target tumor cells but also target the tumor microenvironment, metabolic pathways and interaction of cytokines in tumor cells. The current treatment for primary and recurrent glioblastomas is failing because clinicians are not considering the effect of bone marrow derived cells to the development of resistance to clinically practiced therapies. This book helps readers rethink treatment strategies to successfully fight glioblastomas. It is a valuable resource for cancer researchers, clinicians, graduate students and other members of the biomedical field.",

author = "Arbab, {Ali Syed}",

year = "2021",

month = jan,

day = "1",

doi = "10.1016/C2019-0-04929-1",

language = "English (US)",

isbn = "9780128232767",

publisher = "Elsevier",

address = "Netherlands",

}

TY - BOOK

T1 - New Targeting in The Reversal of Resistant Glioblastomas

AU - Arbab, Ali Syed

PY - 2021/1/1

Y1 - 2021/1/1

N2 - New Targeting in The Reversal of Resistant Glioblastomas discusses alternative treatment strategies that not only target tumor cells but also target the tumor microenvironment, metabolic pathways and interaction of cytokines in tumor cells. The current treatment for primary and recurrent glioblastomas is failing because clinicians are not considering the effect of bone marrow derived cells to the development of resistance to clinically practiced therapies. This book helps readers rethink treatment strategies to successfully fight glioblastomas. It is a valuable resource for cancer researchers, clinicians, graduate students and other members of the biomedical field.

AB - New Targeting in The Reversal of Resistant Glioblastomas discusses alternative treatment strategies that not only target tumor cells but also target the tumor microenvironment, metabolic pathways and interaction of cytokines in tumor cells. The current treatment for primary and recurrent glioblastomas is failing because clinicians are not considering the effect of bone marrow derived cells to the development of resistance to clinically practiced therapies. This book helps readers rethink treatment strategies to successfully fight glioblastomas. It is a valuable resource for cancer researchers, clinicians, graduate students and other members of the biomedical field.

UR - http://www.scopus.com/inward/record.url?scp=85142076279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85142076279&partnerID=8YFLogxK

U2 - 10.1016/C2019-0-04929-1

DO - 10.1016/C2019-0-04929-1

M3 - Book

AN - SCOPUS:85142076279

SN - 9780128232767

BT - New Targeting in The Reversal of Resistant Glioblastomas

PB - Elsevier

ER -

New Targeting in The Reversal of Resistant Glioblastomas

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this